Patent · US Active

Insulin dimer-incretin conjugates

US11058775B2 · kind B2 · utility

0Cited by
5References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 21, 2017
Grant dateJul 13, 2021
Priority date—
Expiry dateMay 22, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P3/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Insulin dimers conjugated to peptides having at least one incretin activity are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.